Navigation Links
Picofemto Deploys Cloud-Based Cliniscan EEG Analytics and Clinical Decision Support

NEW YORK, Oct. 17, 2013 /PRNewswire-iReach/ -- Picofemto LLC, a biomedical software company specializing in neuroanalytics and personalized medicine, is pleased to announce the deployment of its first product, EEG Decision Support, based on its proprietary cloud-based biomedical engine, CliniscanTM.


CliniscanTM, the innovative web-based software as a service (SaaS) platform, provides rapid analysis of complex biomedical data to support clinical decisions by physicians.  In addition, Picofemto's open-standards base design emphasizes security, anonymity, and trust, while enabling partnerships for third party diagnostic algorithms with its dynamic open API. The easy-to-use-web interface addresses the medical community and removes the burden of data manipulation and storage while enhancing interoperability for the physician and the patient.

The product immediately benefits healthcare professionals and institutions, particularly in the neurology field, by providing software that integrates multiple biomedical modalities (EEG, MRI, CT), into a single package that can efficiently process complex data – including quantitative EEG analysis and brain segmentation.  Additionally, CliniscanTM will permit the storage, retrieval, and sharing of digital biomedical files, including DICOM. A number of studies have demonstrated that the primary driver increasing healthcare costs is technology.  Kai Matsumiya, Chief Operating Officer, states "This technology will lower healthcare costs by decreasing both time and cost while increasing efficiency."

The core of the CliniscanTM platform is a custom engine that divides workloads dynamically across a number of computing nodes. This greatly reduces the time required to analyze data sets and to run workflows that are beyond the capabilities of desktop systems.  According to Brian Kennedy, Chief Technology Officer, "The CliniscanTM toolkit accelerates the development of medical data processing algorithms and reduces the complexity of developing parallel distributed code for cloud processing." Brad Johnson, Lead Developer, describes the open API as "providing third party access to partners with scalability to handle complex data." For these reasons, CliniscanTM stands to become the premier open-architecture, self-proliferating repository for third-party diagnostic algorithms.

EEG Decision Support, the first plug-in modality within the CliniscanTM open architecture, is the most comprehensive product of its kind available in the market. Fatih Sirin, Ph.D and Head of Analytics, notes"EEG Decision Support addresses the paramount components of quantitative EEG analysis - insomnia, dementia, epilepsy, head injury, sleep apnea, using an array of "gold standard" algorithms."  Dhinakaran Chinappen, Biomedical Engineer, reports "EEG Decision Support features automated spike detection, seizure detection, classification, thereby saving the physician a substantial amount of time."

Cecily Xi and William Bubel, Senior Software Engineers, emphasize that "Users are provided with a complete, comprehensive, and objective report conveying abnormal characteristics of the EEG recording, clinical correlations, and notes from the physician."  

Picofemto distinguishes itself with the ability to process large scale biomedical data in an efficient manner - within the medical sector which has experienced unprecedented high costs and increased volume. Robert Callan, Quantitative Analyst, is excited about "a wider range of analytics for biomedical modalities including ECG, MRI, CT, and PET that will be deployed in the near future." In addition, because of its cloud-based delivery, Picofemto is planning for international expansion within both the developing and developed world contexts where many would reap the benefits of a critical healthcare component.   

Srikant Krishna, Founder & CEO, states "We are very pleased to have developed this sophisticated product on a very aggressive schedule since inception.  We strongly feel this will be a game-changer in the utilization of technology in healthcare."  There are expected to be significant changes in the healthcare system and practices derived from the Affordable Care Act ("Obamacare").

For more information, please contact Kai Matsumiya at (, +1.212.502.3770). 

Media Contact: Kai Matsumiya, Picofemto, +1.212.502.3770,

News distributed by PR Newswire iReach:

SOURCE Picofemto LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. US Navy Deploys Mobile Biometric Solution Provided by Aware
2. Keeneland Project deploys new GPU supercomputing system for the National Science Foundation
3. Westpak Deploys Horizontal Impact Test System (HITS)
4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
5. Desert Research Institute utilizing IBM big data analytics to assist Nevadas growth strategy
6. UNLV, Sen. Reid Announce $20 Million NIH grant to support clinical health research
7. Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
8. DO-HEALTH a multi-center clinical trial on healthy ageing achieves first milestone
9. With early, obvious benefit of a targeted cancer drug, should expensive clinical testing continue?
10. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
11. UCLA stem cell gene therapy for sickle cell disease advances toward clinical trials
Post Your Comments:
(Date:11/17/2015)... Paris from 17 th until 19 ... from 17 th until 19 th November 2015. ... invented the first combined scanner in the world which scans ... now two different scanners were required: one for passports and ... the same surface. This innovation is an ideal solution for ...
(Date:11/12/2015)... , Nov. 12, 2015  A golden retriever ... Duchenne muscular dystrophy (DMD) has provided a new lead ... Children,s Hospital, the Broad Institute of MIT and Harvard ... Brazil . Cell, pinpoints ... dogs "escape" the disease,s effects. The Boston Children,s lab ...
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 25, 2015 2 ... première fois les différences entre les souches bactériennes ... celles des êtres humains . Ces recherches ... et envisager la prise en charge efficace de ... diagnostiqués chez les chats .    --> ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... ... genomics company uBiome, were featured on AngelList early in their initial angel funding ... an AngelList syndicate for individuals looking to make early stage investments in the ...
(Date:11/24/2015)... Therapeutics, Inc. (NASDAQ: HALO ) will be presenting at the ... on Wednesday, December 2 at 9:30 a.m. ET/6:30 a.m. PT . ... a corporate overview. th Annual Oppenheimer Healthcare Conference ... a.m. PT . Jim Mazzola , vice president of ... --> th Annual Oppenheimer Healthcare Conference in ...
Breaking Biology Technology: